MISP: "Real-world evidence of the impact of access, knowledge, and counseling about the etonogestrel-releasing implant (Implanon NXT®) and the effect on pregnancy rate, reasons and rates for discontinuation, and continuation rate up to two years after insertion in a Brazilian clinic when compared to short-acting reversible contraceptives (SHARC)."
Financing : Schering-Plough Industria Farmacêutica Ltda.
Researcher : Dr. Luis Bahamondes
Line of Research : Contraception, Sexual and Reproductive Health, Immigrants
Associated Search:
To provide a wide comprehension of the MISP implementation status, mechanisms, and objectives (types and delivery modes) among Venezuelan migrants in Roraima State, Brazil – Phase 1 e 2
Financing : WHO – World Health Organization
Researcher : Dr. Luis Bahamondes
